Financial reports
NT 10-Q
Notice of late quarterly filing
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K/A
2021 FY
Annual report (amended)
29 Apr 22
10-K
2021 FY
Annual report
31 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
10-K/A
2020 FY
Annual report (amended)
12 Nov 21
10-Q
2021 Q2
Quarterly report
12 Aug 21
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Sep 22
8-K
Termination of a Material Definitive Agreement
2 Sep 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 Aug 22
8-K
Other Events
11 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
4 Aug 22
8-K
Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split
12 Jul 22
8-K
Entry into a Material Definitive Agreement
11 Jul 22
8-K
Results of Operations and Financial Condition
8 Jul 22
8-K
Allena Pharmaceuticals Announces Rescheduling of Special Meeting
5 Jul 22
8-K
Termination of a Material Definitive Agreement
28 Jun 22
Registration and prospectus
25-NSE
Exchange delisting
14 Sep 22
424B5
Prospectus supplement for primary offering
11 Jul 22
S-1
IPO registration
23 Jun 22
D
$4.05M in options, sold $4.05M, 5 investors
17 May 22
424B5
Prospectus supplement for primary offering
4 May 22
424B5
Prospectus supplement for primary offering
23 Dec 21
424B5
Prospectus supplement for primary offering
23 Dec 21
424B5
Prospectus supplement for primary offering
15 Jul 21
S-3
Shelf registration
6 May 21
424B5
Prospectus supplement for primary offering
30 Mar 21
Proxies
DEFA14A
Additional proxy soliciting materials
13 Jul 22
DEFA14A
Additional proxy soliciting materials
12 Jul 22
DEFA14A
Additional proxy soliciting materials
5 Jul 22
DEFA14A
Additional proxy soliciting materials
24 May 22
DEF 14A
Definitive proxy
24 May 22
PRE 14A
Preliminary proxy
13 May 22
DEFA14A
Additional proxy soliciting materials
4 May 22
DEFA14A
Additional proxy soliciting materials
20 May 21
DEFA14A
Additional proxy soliciting materials
6 May 21
DEFA14A
Additional proxy soliciting materials
22 Apr 21
Other
SEC STAFF ACTION
SEC staff action: Order
12 Jun 23
UPLOAD
Letter from SEC
19 Nov 21
CORRESP
Correspondence with SEC
12 Nov 21
UPLOAD
Letter from SEC
29 Oct 21
EFFECT
Notice of effectiveness
13 May 21
CORRESP
Correspondence with SEC
11 May 21
UPLOAD
Letter from SEC
10 May 21
EFFECT
Notice of effectiveness
7 Dec 20
CORRESP
Correspondence with SEC
2 Dec 20
UPLOAD
Letter from SEC
2 Dec 20
Ownership
SC 13G/A
Third Rock Ventures II, L.P.
14 Feb 23
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 22
4
Richard D Katz
2 Feb 22
4
LOUIS MD BRENNER
2 Feb 22
SC 13G/A
Frazier Healthcare VI, L.P.
28 Jan 22
SC 13G/A
HIRSCHMAN ORIN
25 Jan 22
4
LOUIS MD BRENNER
17 Nov 21
4
Alexey L Margolin
4 Jun 21
4
Robert Alexander
4 Jun 21
4
Allene M. Diaz
4 Jun 21